Remove Biohazard Remove Development Remove Drugs Remove Pharmacy
article thumbnail

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Pharmaceutical Technology

However, stopping nucleation and growth is challenging and often involves the use of biohazardous substances. A major challenge in the top-down approach is the development of an efficient size reduction process by using a highly performant mill. Overcoming the process limitations of wet nanomilling for pharmaceutical drug substances.